Arizton publishes the latest research report, Healthcare Cold Chain Logistics Market – Global Outlook & Forecast 2023-2028. The global healthcare cold chain logistics market to reach USD 27.74 billion by 2028, growing at a CAGR of 5.26%.
To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/3896
Healthcare Cold Chain Logistics Market Report Scope
|Market Size (2028)||USD 27.74 Billion|
|Market Size (2022)||USD 20.39 Billion|
|Market Segmentation||Product, Service, End-User, and Geography|
|Geographic Analysis||North America, Europe, APAC, Latin America, and Middle East & Africa|
The pharmaceutical and healthcare industries are expanding rapidly and developing novel drugs with increased efficacy. These medications require proper storage and refrigeration. This requirement has expanded the scope of healthcare cold chain logistics. Furthermore, pharmaceutical exports are rapidly increasing because several countries’ governments emphasize providing advanced healthcare facilities to their citizens. The demand for a well-equipped healthcare setup is expected to pave the way for new avenues in the global healthcare cold chain logistics market in the coming years.
Increasing Collaborations Between 3PL Providers & Healthcare Providers Uplifting the Market Growth
Most healthcare providers focus on their core business and outsource their secondary business to third-party logistics providers. The increased cost pressures have also created incentives to find innovative ways to serve current and new markets, geographies, and customers. Therefore, healthcare companies have an emerging need for agile and flexible supply chains. Outsourcing provides these companies access to resources and capabilities not available internally. Also, outsourcing frees up human resources and capital and enables these companies to focus on their core business: development, research, and manufacturing of drugs, vaccines, medical supplies, or medical devices. Therefore, many healthcare manufacturers outsource their distribution operations to third-party logistics (3PL) providers.
Collaborating with the right 3PL provider enables manufacturers to expand their capabilities, add markets, and have exceptional flexibility to develop new products. Many healthcare manufacturing companies that have entered into such collaborations have found them cost-effective options. For instance, healthcare cold chain logistics specialists such as United Parcel Service (UPS) provide fully compliant cold chain infrastructure, transportation assets, and worldwide logistics solutions, which enable healthcare companies to lower their expenses. According to a survey by UPS, about 7 out of 10 North American healthcare logistics executives identified distribution and logistics partnerships as a successful way to manage costs.
Buy the Report Now: https://www.arizton.com/market-reports/healthcare-cold-chain-logistics-market
- 1hr of free analyst discussion
- 10% of customization
Pharmaceutical/Biotechnology Companies to Hold the Largest Share
Pharmaceutical/biotechnology companies dominate the end-user segment as they are the primary manufacturers of temperature-sensitive healthcare products. They require cold chain logistics to ensure efficient and timely delivery of medications to the patients and receive raw materials such as APIs to develop several pharmaceutical products. In recent years, there has been a noticeable increase in spending on cold chain logistics, contributing to the market’s growth.
About the Report:
The report considers the present scenario of the healthcare cold chain logistics market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
- DB Group
- Deutsche Post DHL Group
- CEVA Logistics
- United Parcel Service
- Kuehne + Nagel
- AWL India
- A.P. Moller – Maersk
- Cold Chain Technologies
- COREX Logistics
- Cardinal Health
- GXO Logistics
- Kerry Logistics Network
- Lufthansa Cargo
- Nippon Express
- Noatum Logistics
- Phoenix Group
- Parexel International
- Quick International Courier
- SEKO Logistics
- YUSEN LOGISTICS
- Product: Pharmaceuticals, Medical Products, and Others
- Service: Transportation (Road, Water, and Air), Warehousing, and Others
- End-User: Pharmaceutical/Biotech Companies, Hospitals & Clinics, Research & Diagnostic Labs, and Others
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Key Questions Answered in the Report:
- How big is the healthcare cold chain logistics market?
- What is the projected growth rate of the healthcare cold chain logistics market?
- Who are the key players in the global healthcare cold chain logistics market?
- What are the growing trends in the healthcare cold chain logistics market?
- Which region holds the most significant global healthcare cold chain logistics market share?
Check Out Some of the Top Selling Research Reports:
Medical Packaging Films Market – Global Outlook & Forecast 2022-2027
Pharmaceutical Logistics Market – Global Outlook & Forecast 2022-2027
Pharmaceutical Packaging Market – Global Outlook & Forecast 2022-2027
Healthcare Logistics Market – Global Outlook & Forecast 2021-2026
Check the detailed table of contents of the report @ https://www.arizton.com/market-reports/healthcare-cold-chain-logistics-market?details=tableOfContents
Arizton’s Expertise in the Healthcare Industry
Arizton offers syndicate and custom market intelligence & competitive intelligence solutions across MedTech, pharmaceuticals, and life sciences & biotechnology markets within the healthcare industry. Arizton’s healthcare vertical provides unbiased research and evidence-based analysis to support business decisions and comprehensive end-to-end solutions to its customers, covering all dimensions of the healthcare value chain. We track various devices (equipment, implants, and hospital supplies) and drugs (patented, generic, & OTC) across North America, Europe, APAC, Latin America, and the Middle East & Africa regions. The healthcare reports provide historic and forecast data for 20+ key countries worldwide. We track product approvals/launches, M&A activities, and collaboration/partnership activities among pharma/biotech, medical device, and life sciences companies. Our pharmaceutical portfolio tracks 15+ therapy areas with a major focus on immunology, oncology, rare & genetic diseases, dermatology, and metabolic diseases. Our medical devices and life sciences portfolio covers in-vitro diagnostics, healthcare IT, patient monitoring, cardiovascular devices, medical imaging, personal protective equipment, clinical laboratory services, and CMO/CDMO services.
Explore more healthcare reports: https://www.arizton.com/market-reports/category/healthcare-lifesciences
- 100% Customer Satisfaction
- 24×7 availability – we are always there when you need us
- 200+ Fortune 500 Companies trust Arizton’s report
- 80% of our reports are exclusive and first in the industry
- 100% more data and analysis
- 1500+ reports published till date
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.